SCHEMBL487420

SCHEMBL487420

CC(=O)OCc1cccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
EPHX1 P07099 1/20 0.54
TDP1 Q9NUW8 2/20 0.53
ATM Q13315 1/20 0.53
ALDH1A1 P00352 1/20 0.52
PARP10 Q53GL7 1/20 0.51
SLC1A3 P43003 1/20 0.50
SLC1A2 P43004 1/20 0.50
SLC1A1 P43005 1/20 0.50
SIRT5 Q9NXA8 1/20 0.49
FFAR1 O14842 1/20 0.48
AKR1B1 P15121 1/20 0.48
KDM4E B2RXH2 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ACP3 P15309 1/20 0.47
MAPK8 P45983 1/20 0.47
MAPK9 P45984 1/20 0.47
MAPK10 P53779 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9685109 0.89 ALDH1A1 (0.53) KMT2AMEN1EPHX1ATMALDH1A1
SCHEMBL28702056 0.85 TDP1 (0.56) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL21372579 0.85 TDP1 (0.56) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL27585843 0.85 ALDH1A1 (0.51) KMT2AMEN1EPHX1ALDH1A1PARP10
SCHEMBL8083878 0.84 SLC1A3 (0.52) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL2575314 0.84 EPHX1 (0.55) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL2575317 0.84 TDP1 (0.59) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL1130685 0.83 KMT2A (0.50) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL25034482 0.83 ATM (0.57) KMT2AMEN1EPHX1TDP1ATM
SCHEMBL6989892 0.83 CDYL (0.53) KMT2AMEN1TDP1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11583842-B2 Zwitterionic catalysts for (trans)esterification: application in fluoroindole-derivatives and biodiesel synthesis THE CHINESE UNIVERSITY OF HONG KONG (CN) 2023-02-21 US disclosed
WO-2022076820-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-14 WO disclosed
CN-108699493-B Detergent composition 狮王株式会社 2021-10-08 CN disclosed
US-10852637-B2 Pattern forming method, resist pattern, method for manufacturing electronic device, and composition for forming upper layer film FUJIFILM CORPORATION (JP) 2020-12-01 US disclosed
CN-110972858-A Wild angelica sinensis introduction and cultivation method 甘肃步云农牧科技有限责任公司 2020-04-10 CN disclosed
CN-109312025-A The method for being used to prepare organic charge transport film 陶氏环球技术有限责任公司 2019-02-05 CN disclosed
US-20180081277-A1 PATTERN FORMING METHOD, RESIST PATTERN, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND COMPOSITION FOR FORMING UPPER LAYER FILM FUJIFILM CORPORATION (JP) 2018-03-22 US disclosed
US-20170351179-A1 COMPOSITION FOR FORMING UPPER LAYER FILM, PATTERN FORMING METHOD USING THE SAME, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2017-12-07 US disclosed
US-20170322490-A1 PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION FOR ORGANIC SOLVENT DEVELOPMENT FUJIFILM CORPORATION (JP) 2017-11-09 US disclosed
US-9760003-B2 Pattern forming method and actinic-ray- or radiation-sensitive resin composition FUJIFILM CORPORATION (JP) 2017-09-12 US disclosed
US-6562849-B1 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc. SANKYO COMPANY, LIMITED (JP) 2003-05-13 US disclosed
US-20030078426-A1 Amine derivative compounds SANKYO COMPANY, LIMITED (JP) 2003-04-24 US disclosed
WO-2002017973-A2 PREPARING STERILE ARTICLES FROM CERTAIN POLYMERS OCCIDENTAL CHEMICAL CORPORATION (US) 2002-03-07 WO disclosed
EP-1167366-A1 AMINE DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed
CN-1165521-A Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides LAPHAL LABORATOIRES SA (FR) 1997-11-19 CN disclosed
CN-1039028-A The preparation method of novel cpd HAESSLE AB (SE) 1990-01-24 CN disclosed
US-4248976-A COMPRISING A PHOSPHORUS COMPOUND AND AN AROMATIC COMPOUND CIBA-GEIGY AG (CH) 1981-02-03 US disclosed
US-4237051-A Stereospecific production of 6- or 7-carbon-substituted-β-lactams SCHERING CORPORATION (US) 1980-12-02 US disclosed
US-4207224-A Plastics composition CIBA-GEIGY AG (CH) 1980-06-10 US disclosed
US-4172858-A Flame-resistant polymer compositions CIBA-GEIGY AG (CH) 1979-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078426-A1 Amine derivative compounds H1-10, APOB, PRMT1 KMT2A 85/4885MEN1 300/4885EPHX1 3756/4885
US-11583842-B2 Zwitterionic catalysts for (trans)esterification: application in fluoroindole-derivatives and biodiesel synthesis INMT, AADAT, BCHE KMT2A 4110/4885MEN1 672/4885EPHX1 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.